Therefore, therapeutic interventions targeting the overexpression of IL-6 and glucose metabolism may serve as a promising strategy to bolster the immune response against viruses mediated by NK cells, particularly in cases where COVID-19 is comorbid with T2D. The gene discussed is IL6; the disease is type 2 diabetes mellitus.